GE HealthCare's second quarter revenue of $5.3B beats estimates, driven by record orders while the company reaffirms its 2026 outlook.

GE HealthCare reported second quarter 2026 revenue of $5.3 billion, an increase of 5.7% year-over-year, with organic revenue growing 3.5%. Diluted EPS was $1.24, up 16.5% from the prior year. The company reaffirmed its full-year 2026 guidance.

Key Highlights

• The company reported record organic orders growth of 11.1%, leading to a book-to-bill ratio of 1.15 and a total backlog of $23.9 billion.
• Growth was led by the Pharmaceutical Diagnostics segment, with revenue up 15.6%, and the Advanced Imaging Solutions segment, where revenue grew 7.9%.
• The Patient Care Solutions segment significantly underperformed, with revenue declining 13.3% and posting an EBIT loss of $26 million. The company announced it is reviewing strategic options for this business.